Revvity Inc. $RVTY Shares Acquired by Russell Investments Group Ltd.

Key Points

• Russell Investments Group Ltd. increased its holdings in Revvity Inc. by 15.8%, owning 53,693 shares valued at approximately $5.68 million after acquiring an additional 7,306 shares in Q1.
• Recent analyst reports reflect mixed views, with UBS Group upgrading the stock to "buy" while others like Wall Street Zen downgraded it to "hold," resulting in a consensus rating of "Moderate Buy."
• Revvity announced a quarterly dividend of $0.07 per share, representing an annualized dividend of $0.28, with a yield of 0.3%, payable on November 7th to investors of record on October 17th.

Russell Investments Group Ltd. increased its position in shares of Revvity Inc. (NYSE:RVTY - Free Report) by 15.8% in the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 53,693 shares of the company's stock after purchasing an additional 7,306 shares during the period. Russell Investments Group Ltd.'s holdings in Revvity were worth $5,677,000 as of its most recent SEC filing.

Other large investors have also recently added to or reduced their stakes in the company. Optiver Holding B.V. purchased a new position in Revvity during the fourth quarter worth about $33,000. Quarry LP raised its holdings in Revvity by 45.7% during the fourth quarter. Quarry LP now owns 303 shares of the company's stock worth $34,000 after purchasing an additional 95 shares in the last quarter. Vermillion Wealth Management Inc. purchased a new position in Revvity during the fourth quarter worth about $41,000. New Age Alpha Advisors LLC purchased a new position in Revvity during the first quarter worth about $44,000. Finally, Continuum Advisory LLC raised its holdings in Revvity by 39.3% during the fourth quarter. Continuum Advisory LLC now owns 471 shares of the company's stock worth $53,000 after purchasing an additional 133 shares in the last quarter. 86.65% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several research firms recently issued reports on RVTY. UBS Group raised shares of Revvity from a "neutral" rating to a "buy" rating and cut their price target for the stock from $145.00 to $115.00 in a report on Thursday, May 1st. Wall Street Zen cut shares of Revvity from a "buy" rating to a "hold" rating in a report on Sunday, August 3rd. Robert W. Baird cut their price target on shares of Revvity from $127.00 to $125.00 and set an "outperform" rating for the company in a report on Tuesday, April 29th. Evercore ISI dropped their target price on shares of Revvity from $116.00 to $115.00 and set an "outperform" rating for the company in a report on Tuesday, July 8th. Finally, Raymond James Financial reaffirmed an "outperform" rating and issued a $115.00 target price (down from $120.00) on shares of Revvity in a report on Tuesday, July 29th. Ten equities research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company. According to MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average target price of $120.07.

Revvity Trading Up 0.3%

Shares of RVTY opened at $91.7070 on Thursday. The company has a debt-to-equity ratio of 0.43, a current ratio of 3.33 and a quick ratio of 2.75. The firm has a 50 day simple moving average of $94.69 and a 200-day simple moving average of $99.49. Revvity Inc. has a 1-year low of $85.12 and a 1-year high of $129.50. The stock has a market cap of $10.64 billion, a price-to-earnings ratio of 38.86, a price-to-earnings-growth ratio of 2.45 and a beta of 0.91.

Revvity (NYSE:RVTY - Get Free Report) last issued its quarterly earnings data on Monday, July 28th. The company reported $1.18 earnings per share for the quarter, topping analysts' consensus estimates of $1.14 by $0.04. Revvity had a net margin of 10.19% and a return on equity of 7.66%. The business had revenue of $720.28 million during the quarter, compared to analysts' expectations of $711.26 million. During the same period last year, the company posted $1.22 EPS. The company's revenue was up 4.1% on a year-over-year basis. Revvity has set its FY 2025 guidance at 4.850-4.950 EPS. Equities analysts forecast that Revvity Inc. will post 4.94 EPS for the current fiscal year.

Revvity Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, November 7th. Investors of record on Friday, October 17th will be given a dividend of $0.07 per share. The ex-dividend date is Friday, October 17th. This represents a $0.28 dividend on an annualized basis and a yield of 0.3%. Revvity's dividend payout ratio (DPR) is 11.86%.

About Revvity

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.